Submitted by:  Dr. Gary Kohls

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

And, predictably, the incidence of severe disabilities documented as being caused by both Gardasil (Merck) and Cervarix (Glaxo) vaccines [both containing aluminum adjuvants] have dropped dramatically…

Interview at press club in Ministry of Health, Labour and Welfare (Second left: Ms. Nanami Sakai, Representative of National Plaintiffs Association)　June 14, 2018

Five Years Since the Suspension of Proactive Recommendation of the Human Papillomavirus (HPV) Vaccine in Japan – June 14, 2018

 

National Plaintiffs Association for the HPV Vaccines Lawsuits in Japan

Representative   Nanami Sakai

National Attorneys Association for the HPV Vaccines Lawsuits in Japan

Joint Representative   Masumi Minaguchi

Joint Representative   Yoshiaki Yamanishi

 

It has been five years since the Japanese Government halted proactive recommendation of the HPV vaccine on June 14, 2013, claiming that it could not provide the public with enough information. Compared to other routine vaccinations, an average of over seven times the number of serious adverse effects per one million HPV vaccinations have been reported, and the number of disability certifications by the Adverse Drug Reaction Relief System is almost ten times higher.

The government has put in place research groups and selected cooperating medical institutions for the HPV vaccine, but measures to prevent adverse effects and to provide treatment have yet to be established.

The public cannot use the HPV vaccine with peace of mind.

More